Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autonomix Medical Inc

1.85
-0.2000-9.76%
Post-market: 1.880.0300+1.62%18:28 EDT
Volume:59.37K
Turnover:115.74K
Market Cap:4.56M
PE:-0.12
High:2.04
Open:2.04
Low:1.83
Close:2.05
Loading ...

Autonomix to sell 1.38M units at $6.54 in underwritten public offering

TIPRANKS
·
22 Nov 2024

Autonomix Medical Inc - Offering Includes 1.4 Mln Common Stock Units at $6.54 Each

THOMSON REUTERS
·
22 Nov 2024

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

THOMSON REUTERS
·
22 Nov 2024

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

GlobeNewswire
·
22 Nov 2024

As Of September 30, 2024 Autonomix Medical Had Cash Of $5.2M

Benzinga
·
11 Nov 2024

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

THOMSON REUTERS
·
11 Nov 2024

Top Midday Decliners

MT Newswires Live
·
02 Nov 2024

Autonomix Medical Launches Public Offering; Shares Drop

MT Newswires Live
·
01 Nov 2024

Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment

Dow Jones
·
31 Oct 2024

Autonomix Medical Inc trading resumes

TIPRANKS
·
31 Oct 2024

Autonomix Medical, Inc. Reports New Positive Topline Results From First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain With Maintained Pain Reduction

THOMSON REUTERS
·
31 Oct 2024

Autonomix Medical Inc - No Responding Patient Needed Opioids After 24-Hour Follow-up

THOMSON REUTERS
·
31 Oct 2024

Autonomix Medical Inc - 79% Responder Rate Achieved With Zero Opioid Use

THOMSON REUTERS
·
31 Oct 2024

Autonomix Medical, Inc.’s DR. Robert Schwartz Discusses What Positive 4-6 Week Follow-up Data Means From Lead-in Patients in Ongoing Human Clinical Trial

THOMSON REUTERS
·
30 Oct 2024

AMIS Stock Surges After RF Ablation Trial Unveils Positive Results

Zacks
·
29 Oct 2024

S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings

Benzinga
·
29 Oct 2024